There are certainly not many scientific or medical discoveries that, even almost 30 years after their introduction, are still as curent as the description of a single cell death-apoptosis-made by Kerr et al in 1972 .
From a toxicologic pathology point of view, it is remarkable that the discovery of apoptosis (the morphological description of single cell death) was first based only on findings made with a light microscope, with no costly immunohistochemical special stains or investigations with an electron microscope. That is to say, apoptosis was always there in the hematoxylin and eosin standard routine stainings, but never recognized.
Apoptosis is today understood to be the active process of genetically programmed single cell death, which is completed at the end of a cell's life and thus represents an important opposing regulation mechanism to mitosis. This cell death program is started by a number of physiological and pathological regulation mechanisms and plays an important role in, for example, embryo development and immunology. The reduction in size or shrinking cytoplasm of individual cells and karyorrhexis without inflammatory reaction in the surrounding tissue, seen at an early stage by light microscopy, and which is part of the &dquo;typical&dquo; course of apoptosis, has become a part of the histopathological (toxicopathological) diagnostic routine over the past few decades.
Generally, the diagnosis of apoptosis is used separately from that of necrosis; apart from classic single cell death, for example, the apoptotic death of a number of cells with inflammatory reaction has caused many classification difficulties and inaccurate diagnoses.
Because of this uncertainty and the nonuniform use of the terms &dquo;apoptosis&dquo; and &dquo;necrosis,&dquo; the Society of Toxicologic Pathologists is now publishing a manuscript entitled &dquo;The Nomenclature of Cell Death: Recommendations of an ad hoc Committee of the Society of Toxcologic Pathologists&dquo; with their suggestions for long overdue diagnostic clarification and uniformity in the terminology.
These valid recommendations of the Committee are a pragmatic approach to ceasing this confusion in terminology that has arisen in the past, when apoptosis was seen as counterpoint to necrosis. Particularly because there are no methods to exactly differentiate between apoptosis and necrosis, the positive reaction of the terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling test is not convincing because it can be seen in apoptotic as well as in necrotic cells. To again return to the term &dquo;necrosis&dquo; for dead cells in site, as the authors recommend in their excellent paper, facilitates slide reading. The term &dquo;degeneration&dquo; should also be used, in addition to modifiers mentioned below, if cell death is uncertain.
The use of the modifiers &dquo;apoptotic&dquo; for shrinking cytoplasm, &dquo;oncotic&dquo; for the swelling of prelethal cells, or &dquo;mixed apoptotic and oncotic&dquo; gives additional specific information.
Normally, the morphologic impression of a hematoxylin and eosin-stained routine slide, regardless of the way in which the cell died, is the one final diagnostic criterion of toxicologic pathologists; therefore accurate use of the terms recommended in this paper is indispensable.
In summary, this is a well-written paper recommending the use of the term &dquo;necrosis&dquo;-possibly with a modifier-to describe all cases of cell death. The results of the committee will go a long way toward serving to clarify the confusion in the nomenclature of cell death.
